Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
Go back to Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer| (NASDAQ: SNSE) | Delayed: 13.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.85 | 52 Week High | $ | |||
| Open | $13.85 | 52 Week Low | $ | |||
| Day High | $13.85 | P/E | N/A | |||
| Day Low | $13.85 | EPS | $ | |||
| Volume | 3,761,728 | |||||
